论文部分内容阅读
脂粒体(Liposomes)不再是实验室的掌上明珠。患糖尿病人可以口服胰岛素。英国伦敦Chating Cos医院拟定初步临床试验。用磷脂包封物释放到身体特定部位。封装了的药物侧自由地渗透到组织中,而一般未经封装了的药物(游离药物)寸步难行也。如果药物载体能直接打中靶组织,那么药物的用量,可以少人。脂粒体曾用作酶载体治疗酶缺乏症病人。
Liposomes are no longer pearl of the lab. People with diabetes can take insulin. London Chating Cos Hospital to prepare a preliminary clinical trial. Release with phospholipid encapsulation to specific parts of the body. The encapsulated drug side freely penetrates into the tissue, while the general un-encapsulated drug (free drug) is inaccessible. If the drug carrier can hit the target tissue directly, then the amount of drugs, fewer people. Liposomes have been used as enzyme vectors in the treatment of enzyme deficiency patients.